Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
University of Arizona
University of Arizona
Sanofi
Mayo Clinic
Eli Lilly and Company
University of Texas Southwestern Medical Center
University of Milano Bicocca
Eli Lilly and Company
M.D. Anderson Cancer Center
Indiana University
Brown University
OHSU Knight Cancer Institute
Veru Inc.
Big Ten Cancer Research Consortium
University of California, Irvine
Peter MacCallum Cancer Centre, Australia
Abramson Cancer Center at Penn Medicine
Eli Lilly and Company
Eli Lilly and Company